Ariad Pharm Inc (ARIA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2016 | 06-2016 | 03-2016 | 12-2015 | 09-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 305,038 | 273,047 | 160,927 | 230,888 | 282,187 |
| Marketable Securities | 9,627 | 5,497 | 7,421 | 11,407 | 15,138 |
| Receivables | 23,975 | 14,106 | 21,601 | 15,686 | 15,475 |
| Inventories | 2,061 | 903 | 936 | 1,096 | 1,518 |
| Other current assets | 10,538 | 13,567 | 18,343 | 16,120 | 15,217 |
| TOTAL | $351,239 | $307,120 | $209,228 | $275,197 | $329,535 |
| Non-Current Assets | |||||
| PPE Net | 308,966 | 300,962 | 275,762 | 254,082 | 232,263 |
| Intangibles | 5,512 | 5,411 | 6,240 | 6,105 | 3,025 |
| Other Non-Current Assets | 10,874 | 10,874 | 11,319 | 11,308 | 11,316 |
| TOTAL | $325,352 | $317,247 | $293,321 | $271,495 | $246,604 |
| Total Assets | $676,591 | $624,367 | $502,549 | $546,692 | $576,139 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 30,014 | 24,522 | 16,636 | 13,872 | 9,666 |
| Accounts payable and accrued liabilities | 9,260 | 8,111 | 13,132 | 17,013 | 14,865 |
| Accrued Expenses | 30,798 | 30,891 | 35,271 | 47,463 | 39,845 |
| Other current liabilities | 8,348 | 5,297 | 27,567 | 24,324 | 22,628 |
| TOTAL | $110,843 | $100,663 | $125,052 | $132,284 | $115,676 |
| Non-Current Liabilities | |||||
| Long Term Debt | 522,905 | 466,757 | 445,519 | 429,220 | 419,722 |
| Deferred Revenues | 10,890 | 10,550 | 7,852 | 6,763 | 7,976 |
| Other Non-Current Liabilities | 0 | 6,086 | 11,047 | 11,244 | 12,227 |
| TOTAL | $612,097 | $561,593 | $531,509 | $517,549 | $510,113 |
| Total Liabilities | $722,940 | $662,256 | $656,561 | $649,833 | $625,789 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 194,201 | 192,713 | 191,232 | 190,175 | 189,294 |
| Common Shares | 194 | 192 | 191 | 190 | 189 |
| Retained earnings | -1,417,517 | -1,389,690 | -1,499,538 | -1,445,751 | -1,385,880 |
| Other shareholders' equity | 5,041 | 912 | -128 | 3,835 | 4,363 |
| TOTAL | $-46,349 | $-37,889 | $-154,012 | $-103,141 | $-49,650 |
| Total Liabilities And Equity | $676,591 | $624,367 | $502,549 | $546,692 | $576,139 |